What is the approach to managing epistaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Approach to Epistaxis Management

Immediate First-Line Treatment

Position the patient sitting upright with head tilted slightly forward (not backward) and apply firm sustained compression to the soft lower third of the nose for a full 10-15 minutes without checking if bleeding has stopped during this time. 1, 2, 3

  • The patient should breathe through their mouth and spit out blood rather than swallowing it to prevent nausea and allow assessment of ongoing bleeding 2, 3
  • Compression alone resolves the vast majority of anterior epistaxis cases (>90% of all epistaxis) 2, 3, 4
  • Common pitfall: Patients frequently check if bleeding has stopped before 10-15 minutes, which disrupts clot formation and prolongs bleeding 2, 3
  • Common pitfall: Tilting the head backward is incorrect—this causes blood to flow into the airway or stomach rather than stopping the bleed 2, 3

Second-Line Treatment (If Bleeding Persists After Compression)

If bleeding continues after 10-15 minutes of proper compression, clear any clots from the nasal cavity, then apply a topical vasoconstrictor (oxymetazoline or phenylephrine) and resume compression for an additional 5 minutes. 1, 2, 3

  • Spray the vasoconstrictor 2 times into the bleeding nostril 2
  • This approach stops bleeding in 65-75% of epistaxis cases presenting to emergency departments 2, 3, 5
  • Vasoconstrictors can also be applied using cotton pledgets soaked in oxymetazoline or epinephrine 1:1,000 1, 4
  • Caution: Vasoconstrictors may cause cardiac or systemic complications in susceptible patients (those with cardiovascular disease, hypertension) 3

Third-Line Treatment: Nasal Packing

Use nasal packing only when compression and vasoconstrictors fail, when bleeding is life-threatening, or when a posterior bleeding source is suspected (blood flowing into posterior pharynx during compression). 1, 2, 3

Packing Material Selection:

  • For patients on anticoagulants or antiplatelet medications: Use resorbable packing materials (such as Nasopore, Surgicel, Floseal, or gelatin sponge) to reduce bleeding risk when packing is removed 1, 2, 3, 6, 5
  • For patients not on anticoagulants: Either resorbable or non-resorbable materials (Merocel, petroleum jelly gauze, Rapid-Rhino balloon) can be used 1, 5
  • Newer hemostatic materials (thrombin matrix, fibrin glue, hemostatic gauzes) are more effective with fewer complications than traditional packing 5

Special Considerations for Anticoagulated Patients

Initiate first-line treatments (compression, vasoconstrictors, cautery, packing) before considering transfusion, reversal of anticoagulation, or withdrawal of anticoagulant/antiplatelet medications, unless bleeding is life-threatening. 2, 6

  • This approach prioritizes maintaining therapeutic anticoagulation for the underlying indication (stroke prevention, thrombosis prevention) while still controlling epistaxis 2, 6

When to Escalate Care

Refer to otolaryngology or emergency department if: 2, 3

  • Bleeding persists after 15 minutes of continuous proper compression 2, 3
  • Total bleeding duration exceeds 30 minutes over a 24-hour period 2, 6
  • Signs of hemodynamic instability (tachycardia, hypotension, dizziness from blood loss) 2, 6
  • Persistent or recurrent bleeding despite packing 2
  • Suspected posterior epistaxis (more common in elderly, associated with hypertension and atherosclerosis) 7, 4

Advanced Interventions (Specialist-Level)

For refractory cases requiring specialist management: 3, 5

  • Cauterization: Electrocautery is more effective than chemical cauterization (14.5% vs 35.1% recurrence rates) when an anterior bleeding site is identified 3, 5
  • Endoscopic arterial ligation: More effective than conventional packing (97% vs 62% success rate), particularly sphenopalatine artery ligation 5
  • Endovascular embolization: 80% success rate for intractable cases, comparable efficacy to surgical methods 5

Prevention of Recurrence

Once bleeding stops, apply petroleum jelly or nasal emollients to the nasal mucosa regularly to prevent recurrence. 2, 3

  • Use saline nasal sprays regularly to keep nasal mucosa moist 2, 3
  • Recommend humidifiers, especially in dry environments 2, 3
  • Avoid nose picking or rubbing to allow healing 3

Important Historical Factors to Document

Obtain history regarding: 1, 3

  • Personal or family history of bleeding disorders 1, 3
  • Current use of anticoagulants or antiplatelet medications 1, 3
  • Intranasal drug use 3
  • For recurrent bilateral epistaxis: Assess for nasal and oral mucosal telangiectasias (concern for hereditary hemorrhagic telangiectasia) 2

Patient Education

Educate patients and caregivers about: 2

  • Proper home compression technique (10-15 minutes, head forward, no peeking) 2
  • Preventive measures (nasal moisturization, humidification) 2
  • Warning signs requiring immediate medical attention (persistent bleeding >15 minutes, dizziness, hemodynamic instability) 2
  • Type of packing placed (if applicable), timing for removal, and post-procedure care 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Epistaxis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Epistaxis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Epistaxis: Outpatient Management.

American family physician, 2018

Research

Epistaxis Treatment Options: Literature Review.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2023

Guideline

Management of Epistaxis in Patients on Ozempic (Semaglutide)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of anterior and posterior epistaxis.

American family physician, 1991

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.